BIOMAT Database Logo BIOMAT Database Logo

Impact of nelfinavir resistance mutations on in vitro phenotype, fitness, and replication capacity of human immunodeficiency virus type 1 with subtype B and C proteases. 2004

Luis M F Gonzalez, and Rodrigo M Brindeiro, and Renato S Aguiar, and Helena S Pereira, and Celina M Abreu, and Marcelo A Soares, and Amilcar Tanuri
Laboratório de Virologia Molecular, Departamento de Genética, Universidade Federal do Rio de Janeiro, CCS, Bloco A, Cidade Universitária, Ilha do Fundão, 21944-970 Rio de Janeiro, RJ, Brazil.

Human immunodeficiency virus type 1 subtype B and C proteases were manipulated to contain 90M, 88D, or 89L, and their in vitro biological properties were studied. We showed that D30N has significantly more impact in subtype C than in subtype B counterparts, accounting for the reported low prevalence of this mutation in patients failing nelfinavir-based regimens.

UI MeSH Term Description Entries
D007527 Isoenzymes Structurally related forms of an enzyme. Each isoenzyme has the same mechanism and classification, but differs in its chemical, physical, or immunological characteristics. Alloenzyme,Allozyme,Isoenzyme,Isozyme,Isozymes,Alloenzymes,Allozymes
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D011993 Recombinant Fusion Proteins Recombinant proteins produced by the GENETIC TRANSLATION of fused genes formed by the combination of NUCLEIC ACID REGULATORY SEQUENCES of one or more genes with the protein coding sequences of one or more genes. Fusion Proteins, Recombinant,Recombinant Chimeric Protein,Recombinant Fusion Protein,Recombinant Hybrid Protein,Chimeric Proteins, Recombinant,Hybrid Proteins, Recombinant,Recombinant Chimeric Proteins,Recombinant Hybrid Proteins,Chimeric Protein, Recombinant,Fusion Protein, Recombinant,Hybrid Protein, Recombinant,Protein, Recombinant Chimeric,Protein, Recombinant Fusion,Protein, Recombinant Hybrid,Proteins, Recombinant Chimeric,Proteins, Recombinant Fusion,Proteins, Recombinant Hybrid
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D003001 Cloning, Molecular The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells. Molecular Cloning
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012367 RNA, Viral Ribonucleic acid that makes up the genetic material of viruses. Viral RNA
D014162 Transfection The uptake of naked or purified DNA by CELLS, usually meaning the process as it occurs in eukaryotic cells. It is analogous to bacterial transformation (TRANSFORMATION, BACTERIAL) and both are routinely employed in GENE TRANSFER TECHNIQUES. Transfections
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications

Related Publications

Luis M F Gonzalez, and Rodrigo M Brindeiro, and Renato S Aguiar, and Helena S Pereira, and Celina M Abreu, and Marcelo A Soares, and Amilcar Tanuri
Replicative capacity differences of thymidine analog resistance mutations in subtype B and C human immunodeficiency virus type 1.
May 2009, Journal of virology,
Luis M F Gonzalez, and Rodrigo M Brindeiro, and Renato S Aguiar, and Helena S Pereira, and Celina M Abreu, and Marcelo A Soares, and Amilcar Tanuri
Impact of human immunodeficiency virus type 1 subtype C on drug resistance mutations in patients from Botswana failing a nelfinavir-containing regimen.
June 2006, Antimicrobial agents and chemotherapy,
Luis M F Gonzalez, and Rodrigo M Brindeiro, and Renato S Aguiar, and Helena S Pereira, and Celina M Abreu, and Marcelo A Soares, and Amilcar Tanuri
Resistant mechanism against nelfinavir of human immunodeficiency virus type 1 proteases.
January 2005, The journal of physical chemistry. B,
Luis M F Gonzalez, and Rodrigo M Brindeiro, and Renato S Aguiar, and Helena S Pereira, and Celina M Abreu, and Marcelo A Soares, and Amilcar Tanuri
[Screening program on novel drug resistance mutations of subtype B' in human immunodeficiency virus type 1 in China].
May 2011, Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi,
Luis M F Gonzalez, and Rodrigo M Brindeiro, and Renato S Aguiar, and Helena S Pereira, and Celina M Abreu, and Marcelo A Soares, and Amilcar Tanuri
Mutation D30N is not preferentially selected by human immunodeficiency virus type 1 subtype C in the development of resistance to nelfinavir.
June 2004, Antimicrobial agents and chemotherapy,
Luis M F Gonzalez, and Rodrigo M Brindeiro, and Renato S Aguiar, and Helena S Pereira, and Celina M Abreu, and Marcelo A Soares, and Amilcar Tanuri
Clinical significance of human immunodeficiency virus type 1 replication fitness.
October 2007, Clinical microbiology reviews,
Luis M F Gonzalez, and Rodrigo M Brindeiro, and Renato S Aguiar, and Helena S Pereira, and Celina M Abreu, and Marcelo A Soares, and Amilcar Tanuri
Reduced viral replication capacity of human immunodeficiency virus type 1 subtype C caused by cytotoxic-T-lymphocyte escape mutations in HLA-B57 epitopes of capsid protein.
March 2009, Journal of virology,
Luis M F Gonzalez, and Rodrigo M Brindeiro, and Renato S Aguiar, and Helena S Pereira, and Celina M Abreu, and Marcelo A Soares, and Amilcar Tanuri
A reliable phenotype predictor for human immunodeficiency virus type 1 subtype C based on envelope V3 sequences.
May 2006, Journal of virology,
Luis M F Gonzalez, and Rodrigo M Brindeiro, and Renato S Aguiar, and Helena S Pereira, and Celina M Abreu, and Marcelo A Soares, and Amilcar Tanuri
Human Immunodeficiency Virus Type 1 Drug Resistance Mutations Update.
December 2017, The Journal of infectious diseases,
Luis M F Gonzalez, and Rodrigo M Brindeiro, and Renato S Aguiar, and Helena S Pereira, and Celina M Abreu, and Marcelo A Soares, and Amilcar Tanuri
Human immunodeficiency virus type-1 induces a regulatory B cell-like phenotype in vitro.
October 2018, Cellular & molecular immunology,
Copied contents to your clipboard!